SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY)
TRIB 1.060+10.4%3:17 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Carole who wrote (7311)10/30/1997 11:09:00 PM
From: milton  Read Replies (1) of 14328
 
Carole and Ron L.
As to triby's results, the 2 cents is right what the experts predicted-- see stocksmart.com So I don't think today's reports surprised anyone. The wonder is that triby has expended a lot of capital buying up Centcor and more. As the company assimilates the new operations, there will probably be economy of scale and we'll see more efficiency and a resulting increase of profits from existing operations. On top of that we should look to see an expansion of sales with a better resulting p/s and p/e ratio. Right now triby still has a high p/e but forward p/e's should start improving. As to the warrants see post at techstocks.com There is the Nov 1998 expiration on the B's. I question how much B's we have out there. Has anyone seen the number. The answer will be a clue to the dilution effect. Those B's represent a right to exercise at $4 as late as Nov of 1998. Notwithstanding, triby is a great buy and if it doesn't break $10 in the next 10 months I will be surprised. A $20 value in the next 18 is not out of question if growth trends hold.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext